Myia Labs Inc., recently announced it has secured seed funding to accelerate development of its intelligent health monitoring platform. The ACC is collaborating on the platform as part of its Innovation efforts. Designed for both clinicians and their patients, Myia's technology ingests biometric patient data from curated sensors, transforming it through applied machine intelligence into actionable and objective clinical insights. By harnessing the power of human data, the platform augments what clinicians can see from the real-world, equipping them with precise information to optimize care and stage preventative interventions. For patients with chronic and postoperative conditions, like heart failure, Myia helps to avoid emergency hospital visits and sets a new bar on quality of life for those who are aging or homebound. Read more.